Key result
Cardiomyocyte-specific STIM1 deletion in mice resulted in decreased left ventricular contractility (fractional shortening 25.41% vs 39.81%) but attenuated pressure overload-induced cardiac hypertrophy.
Absolute Event Rate: 25.41% vs 39.81%
p-value: p=<0.05
STIM1-dependent Ca2+ microdomains are critical for myofilament remodeling and signaling in the heart, and STIM1 ablation blunts pathological cardiac hypertrophy in response to pressure overload.
STIM1 deletion impairs contractility while attenuating hypertrophy in mice; hypothesis-generating for Ca2+ targets in human pressure-overload states.
In non-excitable cells stromal interaction molecule 1 (STIM1) is a key element in the generation of Ca(2+) signals that lead to gene expression, migration and cell proliferation. A growing body of literature suggests that STIM1 plays a key role in the development of pathological cardiac hypertrophy. However, the precise mechanisms involving STIM-dependent Ca(2+) signaling in the heart are not clearly established. Here, we have investigated the STIM1-associated Ca(2+) signals in cardiomyocytes and their relevance to pathological cardiac remodeling. We show that mice with inducible, cardiac-restricted, ablation of STIM1 exhibited left ventricular reduced contractility, which was corroborated by impaired single cell contractility. The spatial properties of STIM1-dependent Ca(2+) signals determine restricted Ca(2+) microdomains that regulate myofilament remodeling and activate spatially segregated pro-hypertrophic factors. Indeed, mice lacking STIM1 showed less adverse structural remodeling in response to pressure overload-induced cardiac hypertrophy. These results highlight how STIM1-dependent Ca(2+) microdomains have a major impact on intracellular Ca(2+) homeostasis, cytoskeletal remodeling and cellular signaling, even when excitation-contraction coupling is present.
No takes yet. Share an insight, caveat, or question.
Parks et al. (2016) studied Cardiac hypertrophy. STIM1 genetic deletion vs. Wild-type control was evaluated on Fractional shortening (p=<0.05). Cardiomyocyte-specific STIM1 deletion in mice resulted in decreased left ventricular contractility (fractional shortening 25.41% vs 39.81%) but attenuated pressure overload-induced cardiac hypertrophy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: